Introduction
Recent studies 1-5 focused on IMRT treatment plan quality have quantified that the use of inverseplanned radiotherapy does not guarantee a truly optimal treatment plan for every patient. IMRT treatment plan quality assessments are currently compromised by their reliance on individual expertise, alertness, and subjective evaluation, with no effective quantitative measures to ensure high plan quality with respect to what is actually achievable. Plan quality variations can be so great that a significant proportion of patients who should have been at low risk of radiation-induced complications 3 To whom any correspondence should be addressed. are at much higher risk for poor outcome 6 .
To address this problem, we have developed a methodology of model-based algorithms for IMRT treatment plan dose-volume histogram prediction (pDVH) which use patient-specific anatomical features to predict achievable organ at risk (OAR) DVHs. The pDVHs facilitate quantitative assessment of measured vs. expected values for OAR dosimetric parameters, and in this work we describe two separate clinical implementations of this quality control (QC) method.
Model-based predictions for OAR DVHs in IMRT
Our framework for model-based predictions of OAR DVHs was described in Ref. [1] , and here we summarize the method and primary results. The initial assumption for this work involves the identification of a cohort of N site-similar plans that were developed using identical clinical goals and quality assessment criteria. The planning datasets are comprised of structure sets SS ij (i=1...N cases, j=1...M structures with j=1 representing the PTV and j=2...M representing M−1 OARs) and dose matrices , where is the 3-D position vector with arbitrary origin. Operations on D i , SS ij , and derivative structures result in differential and cumulative DVHs for volumes of interest. Figure 1 depicts the pDVH process, whereby the boundary distance vector forms the geometric information that will be correlated to the measured DVHs in the training sets. (The use of this quantity has also been explored by other investigators 2, 4 .) (c) OAR voxels are grouped into iso-distance shells, themselves structures with differential DVHs, or "sub-DVHs" of a full OAR. (d) A skew-normal probability function forms a three-parameter basis function that is used to fit the measured iso-distance sub-DVHs , and (e) the evolution of the skew-normal parameters as a function of distance results in (f) the ability to compute pDVHs for any structure set SS ij on new or prior patients, i.e. in the absence of any D i . Clinical cohorts of 20 prostate and 24 head-and-neck plans trained pDVH models for rectum, bladder, and parotids. Sums-of-residuals (SR) quantified the integrated difference between clinical DVHs and model-predicted DVHs. The predictive ability for new patients was initially evaluated on a cohort of 20 prostate plans. The models identified plans with large SR values, indicating clinical DVHs that significantly exceeded model-predicted DVHs. All plans were replanned, and the correct identification of outliers was assessed by quantifying the correlation between realized dosimetric gains (SR replan -SR original ) and the model-predicted gains (SR original ). The OAR DVHs of the training cohorts were accurately modelled with small mean sums-of-residuals compared to standard deviations. The training and validation sets' sums-of-residuals were statistically indistinguishable, confirming predictive power in new patients. The models exhibited excellent suboptimal plan detection with large correlation coefficients between predicted and realized gains: r rectum =0.92, r bladder =0.88, and r parotid =0.84.
Clinical implementation in Philips PINNACLE 3 treatment planning system
From the perspective of clinical implementation, it is advantageous to incorporate quality control elements directly into the treatment planning system 7 as this reduces the need for extraneous data transfers 5 during the planning process. The results of the prostate pDVH models were encoded into a PINNACLE script that can be executed by the planner for any new patient, and has been in use at Washington University in St. Louis for over a year. The script functions by successive use of PINNACLE's contour expansion and Boolean operations to generate the iso-distance shells depicted in Figure 1c . While this is a very computationally inefficient method, it is mathematically equivalent to direct computation of the boundary distance field. The script then computes volume and sub-DVH information for the OAR shells, which can be used to compute a pDVH for the active plan. As shown in Figure 2 , multiple pDVH models (derived from different training sets) can be presented as feedback to the user who can compare the current DVH to the pDVH(s). In addition to the full DVH curves, discrete DVH cut points can be encoded and displayed, as well as red flags for situations where the active plan exceeds expected variation. With a simple extension of the PINNACLE scripting routines it was also possible to convert a pDVH into IMRT optimization objectives, a facilitating step for automated treatment planning. 
A universal system for predictive DVH modeling and analysis
To support all treatment planning systems (TPS), we developed an efficient DICOM-based tool to create pDVH models for IMRT QC independent of the TPS. RT dose and structure files exported from (Figure 3 ). To date, models have been created for many different treatment sites (intact prostate, prostate bed, head-and-neck, endometrial, cervical, CNS, and lung). MATLAB was used to implement multiple techniques that accelerate the computation of a distance vector field for efficient model building. The program can run on GPUs or, if GPUs are not available, in parallel on multiple CPU cores. The inclusion of GPUs reduces computation time by 200 times, requiring <1 second to compute an OAR vector field and only a few seconds to build a pDVH model. The tool can run in batch mode with minimal user interaction to create a pDVH model for a cohort of patients with a specified treatment site. The tool automatically identifies outliers for treatment plan quality control and pDVH model refinement (Figure 3b ). 
Summary and conclusions
We have demonstrated that the pDVH methodology can serve as an efficient tool for QC of IMRT treatment plans, providing clinicians a novel and highly efficient plan quality control mechanism by predicting OAR DVHs based on local institutional best practices. This technology can be used to facilitate inter-institutional and inter-TPS quality comparisons based on aggregate clinical data instead of contrived benchmark planning sets, as well as facilitating automated planning routines.
